glp-1 gastric emptying Gastric-emptying effects of short-acting versus longer-acting GLP-1 and health: Beyond weight

Glucagon-like peptide-1 (GLP-1)-based therapies, such as semaglutide and tirzepatide, have transformed obesity management, producing weight loss that narrows the gap with metabolic surgery at the same time as reducing the risk of obesity-related complications [2]

Peptides that affect glucose and insulin signaling can aggravate dysglycemia or hide insulin requirements

People who stop taking GLP-1s typically regain some of the weight they've lost and may lose some of the other benefits of the drugs, like the reduced risk of cardiovascular disease

GHK-Cu is a copper peptide, which is a naturally occurring combination of a small protein fragment (GHK) and a copper ion

These mechanisms together suggest that Epitalon doesnt merely act as a passive support molecule but serves as a molecular signal that can unlock telomerase expression, promoting cellular longevity

Hepatology 66 , 18661884 (2017)